Earnings History Data for NRX Pharmaceuticals, Inc. (NRXP) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals Inc. is a patient-focused, clinical stage pharmaceutical company. It creates therapies to treat diseases where no medicines currently exist. NRX Pharmaceuticals Inc., formerly known as Big Rock Partners Acquisition Corp., is based in RADNOR, Pa.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | AH | NRXP | NRX Pharmaceuticals, Inc. | 13.73 | -0.15 | -0.81 | -0.70 | NRx Pharmaceuticals reports Q3 results [11/14/2024 5:25 PM] |
1.19 | 0.03 (2.59%) |
1.20 | 0.04 (3.45%) |
1.10 - 7.33 | 97,954 | 110,000 | 2,912 | ||
| 14-08-2024 | AH | NRXP | NRx Pharmaceuticals | 22.00 | -0.75 | -0.81 | 0.00 | 1.75 | -0.11 (-5.65%) |
2.03 | 0.17 (9.14%) |
1.73 - 7.33 | 80,119 | 70,000 | 1,801 | |||
|
|
||||||||||||||||||
| 14-05-2024 | AH | NRXP | NRX Pharmaceuticals, Inc. | 29.09 | -0.74 | 0.00 | -1.30 | NRx Pharmaceuticals reports Q1 results [5/14/2024 4:23 PM] |
3.20 | 0.02 (0.70%) |
3.08 | -0.10 (-3.14%) |
1.90 - 12.00 | 164,821 | 1,330,000 | 11,851 | ||
| 29-03-2024 | AH | NRXP | NRX Pharmaceuticals, Inc. | 43.30 | -0.05 | -0.06 | -0.15 | NRx Pharmaceuticals reports Preliminary Q4 results and Full Year 2023 Financial Results [3/28/2024 2:53 PM] |
0.4719 | -0.06 (-10.96%) |
0.46 | -0.01 (-2.52%) |
0.22 - 1.20 | 2,442,025 | 1,180,000 | 49,853 | ||
| 14-08-2023 | AH | NRXP | NRX Pharmaceuticals, Inc. | 21.80 | -0.12 | -0.14 | -0.15 | NRx Pharmaceuticals GAAP EPS of -$0.12 [8/14/2023 4:20 PM] |
0.3398 | 0.01 (2.66%) |
0.34 | 0.01 (3.08%) |
0.30 - 1.54 | 567,045 | 490,000 | 44,808 | ||
| 16-05-2023 | PM | 6:45 AM ET (May 16) |
NRXP | NRX Pharmaceuticals, Inc. | 45.08 | -0.13 | -0.15 | -0.25 | NRx Pharmaceuticals GAAP EPS of -$0.16 [5/16/2023 6:51 AM] |
0.67 | -0.03 (-3.80%) |
0.72 | 0.02 (3.03%) |
0.49 - 1.68 | 170,925 | 140,000 | 4,737 | |
| 30-03-2023 | AH | After the close (Mar 30) |
NRXP | NRX Pharmaceuticals, Inc. | 73.78 | -0.15 | -0.14 | -0.09 | NRx Pharmaceuticals GAAP EPS of -$0.61 [3/30/2023 4:13 PM] |
0.6590 | -0.08 (-10.60%) |
0.72 | -0.02 (-2.32%) |
0.49 - 2.70 | 721,193 | 140,000 | 4,191 | |
| 14-11-2022 | PM | 6:50 AM ET (Nov 14) |
NRXP | NRX Pharmaceuticals, Inc. | 59.69 | -0.14 | -0.14 | -0.39 | NRx Pharmaceuticals GAAP EPS of -$0.14 [11/14/2022 6:50 AM] |
0.9007 | -0.10 (-9.93%) |
0.99 | -0.01 (-1.20%) |
0.49 - 10.39 | 464,257 | 270,000 | 14,709 | |
|
||||||||||||||||||
| 15-08-2022 | PM | 7:10 AM ET (Aug 15) |
NRXP | NRX Pharmaceuticals, Inc. | 35.72 | -0.15 | -0.10 | -6.51 | NRx Pharmaceuticals reports Q2 results [8/15/2022 7:00 AM] |
0.7520 | -0.05 (-5.96%) |
0.79 | -0.01 (-1.21%) |
0.49 - 18.30 | 832,668 | 3,080,000 | 233,910 | |
| 16-05-2022 | PM | Before the open (May 16) |
NRXP | NRX Pharmaceuticals, Inc. | 81.30 | -0.25 | 0.00 | -0.09 | NRx Pharmaceuticals GAAP EPS of -$0.21 [5/16/2022 7:14 AM] |
1.35 | 0.03 (2.27%) |
1.44 | 0.12 (9.09%) |
1.15 - 48.80 | 422,987 | 500,000 | 15,628 | |
| 31-03-2022 | PM | Before the open (Mar 31) |
NRXP | NRX Pharmaceuticals, Inc. | 187.91 | -0.09 | 0.00 | 0.00 | NRx Pharmaceuticals GAAP EPS of -$1.98 [3/31/2022 8:26 AM] |
2.45 | -0.40 (-14.04%) |
2.65 | -0.20 (-7.02%) |
2.26 - 48.80 | 2,063,642 | 640,000 | 101,720 | |
|
||||||||||||||||||
| 16-11-2021 | PM | Before the open (Nov 16) |
NRXP | NRX Pharmaceuticals, Inc. | 360.36 | -0.39 | 0.00 | 0.00 | NRx Pharmaceuticals reports Q3 results [11/16/2021 6:01 AM] |
5.96 | -0.24 (-3.87%) |
6.19 | -0.01 (-0.16%) |
5.60 - 76.99 | 994,488 | 1,740,000 | 15,340 | |
| 16-08-2021 | PM | After the close (Aug 16) |
NRXP | NRX Pharmaceuticals, Inc. | 658.35 | -6.51 | 0.00 | 0.00 | NRx Pharmaceuticals reports Q2 results [8/17/2021 2:39 AM] |
12.47 | -1.78 (-12.49%) |
14.00 | -0.25 (-1.75%) |
8.39 - 76.99 | 1,785,687 | 1,760,000 | 8,880 | |